Regulation of adipose tissue lipolysis revisited

Proceedings of the Nutrition Society

Volumn 68, Issue 4, 2009, Pages 350-360

  Bézaire, Véronic ^a,b   Langin, Dominique ^a,b,c  

^a INSERM   (France)

^b UNIVERSITÉ DE TOULOUSE   (France)

^c Biology Institute of Purpan   (France)

Author keywords

Adipose tissue; Lipase; Lipid droplet; Lipolysis

Indexed keywords

CAVEOLIN 1; CELL PROTEIN; COMPARATIVE GENE IDENTIFICATION 58; FATTY ACID BINDING PROTEIN 4; PERILIPIN; TRIACYLGLYCEROL LIPASE; UNCLASSIFIED DRUG; PROTEIN;

ADIPOSE TISSUE; CONFERENCE PAPER; ESTERIFICATION; HORMONAL REGULATION; HUMAN; INFLAMMATION; INSULIN RESISTANCE; LIPOLYSIS; METABOLIC REGULATION; NONHUMAN; OBESITY; PROTEIN LIPID INTERACTION; METABOLISM; PHYSIOLOGY; REVIEW; SIGNAL TRANSDUCTION; WHITE ADIPOSE TISSUE;

ADIPOCYTES, WHITE; ADIPOSE TISSUE; HUMANS; INFLAMMATION; INSULIN RESISTANCE; LIPOLYSIS; OBESITY; PROTEINS; SIGNAL TRANSDUCTION;

EID: 77949325740     PISSN: 00296651     EISSN: 14752719     Source Type: Journal    
DOI: 10.1017/S0029665109990279     Document Type: Conference Paper

References (149)

1. Frayn KN (2002) Adipose tissue as a buffer for daily lipid flux. Diabetologia 45, 1201-1210.
2. Arner P (2003) The adipocyte in insulin resistance: key molecules and the impact of the thiazolidinediones. Trends Endocrinol Metab 14, 137-145.
3. Jensen MD, Haymond MW, Rizza RA et al. (1989) Influence of body fat distribution on free fatty acid metabolism in obesity. J Clin Invest 83, 1168-1173.
4. Lafontan M & Berlan M (1995) Fat cell a2-adrenoceptors: the regulation of fat cell function and lipolysis. Endocrine Rev 16, 716-738.
5. Stich V, De Glisezinski I, Crampes F et al. (2000) Activation of a2-adrenergic receptors impairs exercise-induced lipolysis in SCAT of obese subjects. Am J Physiol 279, 499-504.
6. Sengenes C, Berlan M, De Glisezinski I et al. (2000) Natriuretic peptides: a new lipolytic pathway in human adipocytes. FASEB J 14, 1345-1351.
7. Moro C, Crampes F, Sengenes C et al. (2004) Atrial natriuretic peptide contributes to physiological control of lipid mobilization in humans. FASEB J 18, 908-910.
8. Lafontan M, Moro C, Sengenes C et al. (2005) An unsuspected metabolic role for atrial natriuretic peptides: the control of lipolysis, lipid mobilization, and systemic nonesterified fatty acids levels in humans. Arterioscler Thromb Vasc Biol 25, 2032-2042.
9. Bjorntorp P & Furman RH (1962) Lipolytic activity in rat epididymal fat pads. Am J Physiol 203, 316-322.
10. Rizack MA (1964) Activation of an epinephrine-sensitive lipolytic activity from adipose tissue by adenosine 30,50-phosphate. J Biol Chem 239, 392-395.
11. Holm C, Belfrage P & Fredrikson G (1987) Immunological evidence for the presence of hormone-sensitive lipase in rat tissues other than adipose tissue. Biochem Biophys Res Commun 148, 99-105.
12. Fredrikson G, Stralfors P, Nilsson NO et al. (1981) Hormone-sensitive lipase of rat adipose tissue. Purification and some properties. J Biol Chem 256, 6311-6320.
13. Grober J, Lucas S, Sorhede-Winzell M et al. (2003) Hormone- sensitive lipase is a cholesterol esterase of the intestinal mucosa. J Biol Chem 278, 6510-6515.
14. Strom K, Gundersen TE, Hansson O et al. (2009) Hormone-sensitive lipase (HSL) is also a retinyl ester hydrolase: evidence from mice lacking HSL. FASEB J (Epublication ahead of print version; doi: 10.1096/fj.08- 120923).
15. Langin D, Lucas S & Lafontan M (2000) Millenium fat-cell lipolysis reveals unsuspected novel tracks. Horm Metab Res 32, 443-452.
16. Raclot T, Langin D, Lafontan M et al. (1997) Selective release of human adipocyte fatty acids according to molecular structure. Biochem J 324, 911-915.
17. Holm C, Kirchgessner TG, Svenson KL et al. (1988) Hormone- sensitive lipase: sequence, expression, and chromosomal localization to 19 cent-q13.3. Science 241, 1503-1506.
18. Langin D, Laurell H, Stenson Holst L et al. (1993) Gene organization and primary structure of human hormonesensitive lipase: possible significance of a sequence homology with a lipase of Moraxella TA144, an antarctic bacterium. Proc Natl Acad Sci U S A 90, 4897-4901.
19. Osterlund T (2001) Structure-function relationships of hormone- sensitive lipase. Eur J Biochem 268, 1899-1907.
20. Shen WJ, Sridhar K, Bernlohr DA et al. (1999) Interaction of rat hormone-sensitive lipase with adipocyte lipid-binding protein. Proc Natl Acad Sci U S A 96, 5528-5532.
21. Anthonsen MW, Rönnstrand L, Wernstedt C et al. (1998) Identification of novel phosphorylation sites in hormonesensitive lipase that are phosphorylated in response to isoproterenol and govern activation properties in vitro. J Biol Chem 273, 215-221.
22. Contreras JA, Danielsson B, Johansson C et al. (1998) Human hormone-sensitive lipase: expression and large-scale purification from a baculovirus/insect cell system. Protein Expr Purif 12, 93-99.
23. Shen WJ, Patel S, Natu V et al. (1998) Mutational analysis of structural features of rat hormone-sensitive lipase. Biochemistry 37, 8973-8979.
24. Su CL, Sztalryd C, Contreras JA et al. (2003) Mutational analysis of the hormone-sensitive lipase translocation reaction in adipocytes. J Biol Chem 278, 43615-43619.
25. Egan JJ, Greenberg AS, Chang M-K et al. (1992) Mechanism of hormone-stimulated lipolysis in adipocytes: Translocation of hormone-sensitive lipase to the lipid storage droplet. Proc Natl Acad Sci U S A 89, 8537-8541.
26. Brasaemle DL, Levin DM, Adler-Wailes DC et al. (2000) The lipolytic stimulation of 3T3-L1 adipocytes promotes the translocation of hormone-sensitive lipase to the surfaces of lipid storage droplets. Biochim Biophys Acta 1483, 251-262.
27. Clifford GM, Londos C, Kraemer FB et al. (2000) Translocation of hormone-sensitive lipase and perilipin upon lipolytic stimulation of rat adipocytes. J Biol Chem 275, 5011-5015.
28. Krintel C, Osmark P, Larsen MR et al. (2008) Ser649 and Ser650 are the major determinants of protein kinase Amediated activation of human hormone-sensitive lipase against lipid substrates. PLoS ONE 3, e3756.
29. Greenberg AS, Shen WJ, Muliro K et al. (2001) Stimulation of lipolysis and hormone-sensitive lipase via the extracellular signal-regulated kinase pathway. J Biol Chem 276, 45456-45461.
30. Zhang HH, Halbleib M, Ahmad F et al. (2002) Tumor necrosis factor-alpha stimulates lipolysis in differentiated human adipocytes through activation of extracellular signalrelated kinase and elevation of intracellular cAMP. Diabetes 51, 2929-2935.
31. Kahn BB, Alquier T, Carling D et al. (2005) AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism. Cell Metab 1, 15-25.
32. Roepstorff C, Vistisen B, Donsmark M et al. (2004) Regulation of hormone-sensitive lipase activity and Ser563 and Ser565 phosphorylation in human skeletal muscle during exercise. J Physiol 560, 551-562.
33. Garton AJ & Yeaman SJ (1990) Identification and role of the basal phosphorylation site on hormone-sensitive lipase. Eur J Biochem 191, 245-250.
34. Daval M, Diot-Dupuy F, Bazin R et al. (2005) Antilipolytic action of AMP-activated protein kinase in rodent adipocytes. J Biol Chem 280, 25250-25257.
35. Haemmerle G, Zimmermann R, Hayn M et al. (2002) Hormone- sensitive lipase deficiency in mice causes diglyceride accumulation in adipose tissue, muscle, and testis. J Biol Chem 277, 4806-4815.
36. Kershaw EE, Hamm JK, Verhagen LA et al. (2006) Adipose triglyceride lipase: function, regulation by insulin, and comparison with adiponutrin. Diabetes 55, 148-157.
37. Miyoshi H, Perfield JW 2nd, Obin MS et al. (2008) Adipose triglyceride lipase regulates basal lipolysis and lipid droplet size in adipocytes. J Cell Biochem 105, 1430-1436.
38. Bezaire V, Mairal A, Ribet C et al. (2009) Contribution of adipose triglyceride lipase and hormone-sensitive lipase to fatty acid metabolism in human hMADS adipocytes. J Biol Chem 284, 18282-18291.
39. Schweiger M, Schreiber R, Haemmerle G et al. (2006) Adipose triglyceride lipase and hormone-sensitive lipase are the major enzymes in adipose tissue triacylglycerol catabolism. J Biol Chem 281, 40236-40241.
40. Langin D, Dicker A, Tavernier G et al. (2005) Adipocyte lipases and defect of lipolysis in human obesity. Diabetes 54, 3190-3197.
41. Mairal A, Langin D, Arner P et al. (2006) Human adipose triglyceride lipase (PNPLA2) is not regulated by obesity and exhibits low in vitro triglyceride hydrolase activity. Diabetologia 49, 1629-1636.
42. Lucas S, Tavernier G, Tiraby C et al. (2003) Expression of human hormone-sensitive lipase in white adipose tissue of transgenic mice increases lipase activity but does not enhance in vitro lipolysis. J Lipid Res 44, 154-163.
43. Zimmermann R, Strauss JG, Haemmerle G et al. (2004) Fat mobilization in adipose tissue is promoted by adipose triglyceride lipase. Science 306, 1383-1386.
44. Jenkins CM, Mancuso DJ, Yan W et al. (2004) Identification, cloning, expression, and purification of three novel human calcium-independent phospholipase A2 family members possessing triacylglycerol lipase and acylglycerol transacylase activities. J Biol Chem 279, 48968-48975.
45. Villena JA, Roy S, Sarkadi-Nagy E et al. (2004) Desnutrin, an adipocyte gene encoding a novel patatin domain-containing protein, is induced by fasting and glucocorticoids: ectopic expression of desnutrin increases triglyceride hydrolysis. J Biol Chem 279, 47066-47075.
46. Lake AC, Sun Y, Li JL et al. (2005) Expression, regulation, and triglyceride hydrolase activity of Adiponutrin family members. J Lipid Res 46, 2477-2487.
47. Schweiger M, Schoiswohl G, Lass A et al. (2008) The C-terminal region of human adipose triglyceride lipase affects enzyme activity and lipid droplet binding. J Biol Chem 283, 17211-17220.
48. Kobayashi K, Inoguchi T, Maeda Y et al. (2008) The lack of the C-terminal domain of adipose triglyceride lipase causes neutral lipid storage disease through impaired interactions with lipid droplets. J Clin Endocrinol Metab 93, 2877-2884.
49. Bartz R, Zehmer JK, Zhu M et al. (2007) Dynamic activity of lipid droplets: protein phosphorylation and GTP-mediated protein translocation. J Proteome Res 6, 3256-3265
50. Haemmerle G, Lass A, Zimmermann R et al. (2006) Defective lipolysis and altered energy metabolism in mice lacking adipose triglyceride lipase. Science 312, 734-737.
51. Tornqvist H & Belfrage P (1976) Purification and some properties of a monoacylglycerol-hydrolyzing enzyme of rat adipose tissue. J Biol Chem 251, 813-819.
52. Karlsson M, Contreras JA, Hellman U et al. (1997) cDNA cloning, tissue distribution, and identification of the catalytic triad of monoglyceride lipase. Evolutionary relationship to esterases, lysophospholipases, and haloperoxidases. J Biol Chem 272, 27218-27223.
53. Fredrikson G, Tornqvist H & Belfrage P (1986) Hormonesensitive lipase and monoacylglycerol lipase are both required for complete degradation of adipocyte triacylglycerol. Biochim Biophys Acta 876, 288-293.
54. Wolins NE, Quaynor BK, Skinner JR et al. (2005) S3-12, Adipophilin, and TIP47 package lipid in adipocytes. J Biol Chem 280, 19146-19155.
55. Wolins NE, Skinner JR, Schoenfish MJ et al. (2003) Adipocyte protein S3-12 coats nascent lipid droplets. J Biol Chem 278, 37713-37721.
56. Greenberg A, Egan JJ, Wek SA et al. (1991) Perilipin, a major hormonally regulated adipocyte-specific phosphoprotein associated with the periphery of lipid storage droplets. J Biol Chem 266, 11341-11346.
57. Greenberg AS, Egan JJ, Wek SA et al. (1993) Isolation of cDNAs for perilipins A and B: sequence and expression of lipid droplet-associated proteins of adipocytes. Proc Natl Acad Sci U S A 90, 12035-12039.
58. Martinez-Botas J, Anderson JB, Tessier D et al. (2000) Absence of perilipin results in leanness and reverses obesity in Leprdb/db mice. Nat Genet 26, 474-479.
59. Tansey JT, Sztalryd C, Gruia-Gray J et al. (2001) Perilipin ablation results in a lean mouse with aberrant adipocyte lipolysis, enhanced leptin production, and resistance to dietinduced obesity. Proc Natl Acad Sci U S A 98, 6494-6499.
60. Brasaemle DL, Rubin B, Harten IA et al. (2000) Perilipin A increases triacylglycerol storage by decreasing the rate of triacylglycerol hydrolysis. J Biol Chem 275, 38486-38493.
61. Subramanian V, Garcia A, Sekowski A et al. (2004) Hydrophobic sequences target and anchor perilipin A to lipid droplets. J Lipid Res 45, 1983-1991.
62. Garcia A, Subramanian V, Sekowski A et al. (2004) The amino and carboxyl termini of perilipin a facilitate the storage of triacylglycerols. J Biol Chem 279, 8409-8416.
63. Sztalryd C, Xu G, Dorward H et al. (2003) Perilipin A is essential for the translocation of hormone-sensitive lipase during lipolytic activation. J Cell Biol 161, 1093-1103.
64. Granneman JG, Moore HP, Granneman RL et al. (2007) Analysis of lipolytic protein trafficking and interactions in adipocytes. J Biol Chem 282, 5726-5735.
65. Nishiu J, Tanaka T & Nakamura Y (1998) Isolation and chromosomal mapping of the human homolog of perilipin (PLIN), a rat adipose tissue-specific gene, by differential display method. Genomics 48, 254-257.
66. Egan JJ, Greenberg AS, Chang MK et al. (1990) Control of endogenous phosphorylation of the major cAMP-dependent protein kinase substrate in adipocytes by insulin and betaadrenergic stimulation. J Biol Chem 265, 18769-21875
67. Miyoshi H, Perfield JW 2nd, Souza SC et al. (2007) Control of adipose triglyceride lipase action by serine 517 of perilipin A globally regulates protein kinase A-stimulated lipolysis in adipocytes. J Biol Chem 282, 996-1002.
68. Marcinkiewicz A, Gauthier D, Garcia A et al. (2006) The phosphorylation of serine 492 of perilipin a directs lipid droplet fragmentation and dispersion. J Biol Chem 281, 11901-11909.
69. Palade GE (1953) An electron microscope study of the mitochondrial structure. J Histochem Cytochem 1, 188-211.
70. Patel HH, Murray F & Insel PA (2008) Caveolae as organizers of pharmacologically relevant signal transduction molecules. Annu Rev Pharmacol Toxicol 48, 359-391.
71. Thorn H, Stenkula KG, Karlsson M et al. (2003) Cell surface orifices of caveolae and localization of caveolin to the necks of caveolae in adipocytes. Mol Biol Cell 14, 3967-3976.
72. Parton RG, Hanzal-Bayer M & Hancock JF (2006) Biogenesis of caveolae: a structural model for caveolin-induced domain formation. J Cell Sci 119, 787-796.
73. Drab M, Verkade P, Elger M et al. (2001) Loss of caveolae, vascular dysfunction, and pulmonary defects in caveolin-1 gene-disrupted mice. Science 293, 2449-2452.
74. Trigatti BL, Anderson RG & Gerber GE (1999) Identification of caveolin-1 as a fatty acid binding protein. Biochem Biophys Res Commun 255, 34-39.
75. Fujimoto T, Kogo H, Ishiguro K et al. (2001) Caveolin-2 is targeted to lipid droplets, a new 'membrane domain' in the cell. J Cell Biol 152, 1079-1085.
76. Ostermeyer AG, Paci JM, Zeng Y et al. (2001) Accumulation of caveolin in the endoplasmic reticulum redirects the protein to lipid storage droplets. J Cell Biol 152, 1071-1078.
77. Pol A, Luetterforst R, Lindsay M et al. (2001) A caveolin dominant negative mutant associates with lipid bodies and induces intracellular cholesterol imbalance. J Cell Biol 152, 1057-1070.
78. Brasaemle DL, Dolios G, Shapiro L et al. (2004) Proteomic analysis of proteins associated with lipid droplets of basal and lipolytically stimulated 3T3-L1 adipocytes. J Biol Chem 279, 46835-46842.
79. Cohen AW, Razani B, Schubert W et al. (2004) Role of caveolin-1 in the modulation of lipolysis and lipid droplet formation. Diabetes 53, 1261-1270.
80. Razani B, Rubin CS & Lisanti MP (1999) Regulation of cAMP-mediated signal transduction via interaction of caveolins with the catalytic subunit of protein kinase A. J Biol Chem 274, 26353-26360.
81. Bernlohr DA, Doering TL, Kelly TJ Jr et al. (1985) Tissue specific expression of p422 protein, a putative lipid carrier, in mouse adipocytes. Biochem Biophys Res Commun 132, 850-855.
82. Matarese V & Bernlohr DA (1988) Purification of murine adipocyte lipid-binding protein. Characterization as a fatty acid- and retinoic acid-binding protein. J Biol Chem 263, 14544-14551.
83. Coe NR & Bernlohr DA (1998) Physiological properties and functions of intracellular fatty acid-binding proteins. Biochim Biophys Acta 1391, 287-306.
84. Hertzel AV & Bernlohr DA (2000) The mammalian fatty acid-binding protein multigene family: molecular and genetic insights into function. Trends Endocrinol Metab 11, 175-180.
85. Jenkins-Kruchten AE, Bennaars-Eiden A, Ross JR et al. (2003) Fatty acid-binding protein-hormone-sensitive lipase interaction. Fatty acid dependence on binding. J Biol Chem 278, 47636-47643.
86. Smith AJ, Sanders MA, Thompson BR et al. (2004) Physical association between the adipocyte fatty acid-binding protein and hormone-sensitive lipase: a fluorescence resonance energy transfer analysis. J Biol Chem 279, 52399-52405.
87. Schrag JD & Cygler M (1997) Lipases and alpha/beta hydrolase fold. Methods Enzymol 284, 85-107.
88. Subramanian V, Rothenberg A, Gomez C et al. (2004) Perilipin A mediates the reversible binding of CGI-58 to lipid droplets in 3T3-L1 adipocytes. J Biol Chem 279, 42062-42071.
89. Lass A, Zimmermann R, Haemmerle G et al. (2006) Adipose triglyceride lipase-mediated lipolysis of cellular fat stores is activated by CGI-58 and defective in Chanarin- Dorfman Syndrome. Cell Metab 3, 309-319.
90. Yamaguchi T, Omatsu N, Matsushita S et al. (2004) CGI-58 interacts with perilipin and is localized to lipid droplets. Possible involvement of CGI-58 mislocalization in Chanarin- Dorfman syndrome. J Biol Chem 279, 30490-30497.
91. Ghosh AK, Ramakrishnan G, Chandramohan C et al. (2008) CGI-58, the causative gene for Chanarin-Dorfman syndrome, mediates acylation of lysophosphatidic acid. J Biol Chem 283, 24525-24533.
92. Lefevre C, Jobard F, Caux F et al. (2001) Mutations in CGI- 58, the gene encoding a new protein of the esterase/lipase/ thioesterase subfamily, in Chanarin-Dorfman syndrome. Am J Hum Genet 69, 1002-1012.
93. Akiyama M, Sawamura D, Nomura Y et al. (2003) Truncation of CGI-58 protein causes malformation of lamellar granules resulting in ichthyosis in Dorfman-Chanarin syndrome. J Invest Dermatol 121, 1029-1034.
94. Granneman JG & Moore HP (2008) Location, location: protein trafficking and lipolysis in adipocytes. Trends Endocrinol Metab 19, 3-9.
95. Brasaemle DL (2007) Thematic review series: adipocyte biology. The perilipin family of structural lipid droplet proteins: stabilization of lipid droplets and control of lipolysis. J Lipid Res 48, 2547-2559.
96. Smith AJ, Thompson BR, Sanders MA et al. (2007) Interaction of the adipocyte fatty acid-binding protein with the hormone-sensitive lipase: regulation by fatty acids and phosphorylation. J Biol Chem 282, 32424-32432.
97. Coe NR, Simpson MA & Bernlohr DA (1999) Targeted disruption of the adipocyte lipid-binding protein (aP2 protein) gene impairs fat cell lipolysis and increases cellular fatty acid levels. J Lipid Res 40, 967-972.
98. Newsholme EA (1978) Substrate cycles: their metabolic, energetic and thermic consequences in man. Biochem Soc Symp 43, 183-205.
99. Forest C, Tordjman J, Glorian M et al. (2003) Fatty acid recycling in adipocytes: a role for glyceroneogenesis and phosphoenolpyruvate carboxykinase. Biochem Soc Trans 31, 1125-1129.
100. Reshef L, Hanson RW & Ballard FJ (1969) Glyceride-glycerol synthesis from pyruvate. Adaptive changes in phosphoenolpyruvate carboxykinase and pyruvate carboxylase in adipose tissue and liver. J Biol Chem 244, 1994-2001.
101. Franckhauser S, Antras-Ferry J, Robin P et al. (1995) Expression of the phosphoenolpyruvate carboxykinase gene in 3T3-F442A adipose cells: opposite effects of dexamethasone and isoprenaline on transcription. Biochem J 305, 65-71.
102. Vaughan M (1962) The production and release of glycerol by adipose tissue incubated in vitro. J Biol Chem 237, 3354-3358.
103. Wolfe RR, Herndon DN, Jahoor F et al. (1987) Effect of severe burn injury on substrate cycling by glucose and fatty acids. N Engl J Med 317, 403-408.
104. Hammond VA & Johnston DG (1987) Substrate cycling between triglyceride and fatty acid in human adipocytes. Metabolism 36, 308-313.
105. Reshef L, Olswang Y, Cassuto H et al. (2003) Glyceroneogenesis and the triglyceride/fatty acid cycle. J Biol Chem 278, 30413-30416.
106. Wang T, Zang Y, Ling W et al. (2003) Metabolic partitioning of endogenous fatty acid in adipocytes. Obes Res 11, 880-887.
107. Coppack SW, Frayn KN, Humphreys SM et al. (1989) Effects of insulin on human adipose tissue metabolism in vivo. Clin Sci (Lond) 77, 663-670.
108. Wolfe RR, Klein S, Carraro F et al. (1990) Role of triglyceride- fatty acid cycle in controlling fat metabolism in humans during and after exercise. Am J Physiol 258, E382-E389.
109. Edens NK, Leibel RL & Hirsch J (1990) Mechanism of free fatty acid re-esterification in human adipocytes in vitro. J Lipid Res 31, 1423-1431.
110. Edens NK, Leibel RL & Hirsch J (1990) Lipolytic effects on diacylglycerol accumulation in human adipose tissue in vitro. J Lipid Res 31, 1351-1359.
111. Large V, Reynisdottir S, Langin D et al. (1999) Decreased expression and function of adipocyte hormone-sensitive lipase in subcutaneous fat cells of obese subjects. J Lipid Res 40, 2059-2066.
112. Weisberg SP, McCann D, Desai M et al. (2003) Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 112, 1796-1808.
113. Xu H, Barnes GT, Yang Q et al. (2003) Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 112, 1821-1830.
114. Hotamisligil GS, Shargill NS & Spiegelman BM (1993) Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 259, 87-91.
115. Furuhashi M, Tuncman G, Gorgun CZ et al. (2007) Treatment of diabetes and atherosclerosis by inhibiting fattyacid- binding protein aP2. Nature 447, 959-965.
116. Furuhashi M, Fucho R, Gorgun CZ et al. (2008) Adipocyte/ macrophage fatty acid-binding proteins contribute to metabolic deterioration through actions in both macrophages and adipocytes in mice. J Clin Invest 118, 2640-2650.
117. Cao H, Gerhold K, Mayers JR et al. (2008) Identification of a lipokine, a lipid hormone linking adipose tissue to systemic metabolism. Cell 134, 933-944.
118. Zhang B, Berger J, Hu E et al. (1996) Negative regulation of peroxisome proliferator-activated receptorgamma gene expression contributes to the antiadipogenic effects of tumor necrosis factor-alpha. Mol Endocrinol 10, 1457-1466.
119. Sumida M, Sekiya K, Okuda H et al. (1990) Inhibitory effect of tumor necrosis factor on gene expression of hormone sensitive lipase in 3T3-L1 adipocytes. J Biochem 107, 1-2.
120. Kralisch S, Klein J, Lossner U et al. (2005) Isoproterenol, TNFalpha, and insulin downregulate adipose triglyceride lipase in 3T3-L1 adipocytes. Mol Cell Endocrinol 240, 43-49.
121. Kim JY, Tillison K, Lee JH et al. (2006) The adipose tissue triglyceride lipase ATGL/PNPLA2 is downregulated by insulin and TNF-alpha in 3T3-L1 adipocytes and is a target for transactivation by PPARgamma. Am J Physiol Endocrinol Metab 291, E115-E127.
122. Engelman JA, Berg AH, Lewis RY et al. (2000) Tumor necrosis factor alpha-mediated insulin resistance, but not dedifferentiation, is abrogated by MEK1/2 inhibitors in 3T3-L1 adipocytes. Mol Endocrinol 14, 1557-1569.
123. Fujishiro M, Gotoh Y, Katagiri H et al. (2003) Three mitogen-activated protein kinases inhibit insulin signaling by different mechanisms in 3T3-L1 adipocytes. Mol Endocrinol 17, 487-497.
124. Gasic S, Tian B & Green A (1999) Tumor necrosis factor alpha stimulates lipolysis in adipocytes by decreasing Gi protein concentrations. J Biol Chem 274, 6770-6775.
125. Ryden M, Arvidsson E, Blomqvist L et al. (2004) Targets for TNF-alpha-induced lipolysis in human adipocytes. Biochem Biophys Res Commun 318, 168-175.
126. Botion LM, Brasier AR, Tian B et al. (2001) Inhibition of proteasome activity blocks the ability of TNF alpha to down-regulate G(i) proteins and stimulate lipolysis. Endocrinology 142, 5069-5075.
127. Souza SC, Vargas LMd, Yamamoto MT et al. (1998) Overexpression of perilipin A and B blocks the ability of tumor necrosis factor-a to increase lipolysis in 3T3-L1 adipocytes. J Biol Chem 273, 24665-24669.
128. Souza SC, Palmer HJ, Kang YH et al. (2003) TNF-alpha induction of lipolysis is mediated through activation of the extracellular signal related kinase pathway in 3T3-L1 adipocytes. J Cell Biochem 89, 1077-1086.
129. Fontana L, Eagon J, Trujillo M et al. (2007) Visceral fat adipokine secretion is associated with systemic inflammation in obese humans. Diabetes 56, 1010-1013.
130. Bastard JP, Jardel C, Bruckert E et al. (2000) Elevated levels of interleukin 6 are reduced in serum and subcutaneous adipose tissue of obese women after weight loss. J Clin Endocrinol Metab 85, 3338-3342.
131. Vozarova B, Weyer C, Hanson K et al. (2001) Circulating interleukin-6 in relation to adiposity, insulin action, and insulin secretion. Obes Res 9, 414-417.
132. Petersen EW, Carey AL, Sacchetti M et al. (2005) Acute IL-6 treatment increases fatty acid turnover in elderly humans in vivo and in tissue culture in vitro. Am J Physiol Endocrinol Metab 288, E155-E162.
133. Päth G, Bornstein SR, Gurniak M et al. (2001) Human breast adipocytes express interleukin-6 (IL-6) and its receptor system: increased IL-6 production by beta-adrenergic activation and effects of IL-6 on adipocyte function. J Clin Endocrinol Metab 86, 2281-2288.
134. Rotter V, Nagaev I & Smith U (2003) Interleukin-6 (IL-6) induces insulin resistance in 3T3-L1 adipocytes and is, like IL-8 and tumor necrosis factor-a, overexpressed in human fat cells from insulin resistant subjects. J Biol Chem 278, 45777-45784.
135. Lagathu C, Bastard J-P, Auclair M et al. (2003) Chronic interleukin-6 (IL-6) treatment increased IL-6 secretion and induced insulin resistance in adipocyte: prevention by rosiglitazone. Biochem Biophys Res Commun 311, 372-379.
136. Yang Y, Ju D, Zhang M et al. (2008) Interleukin-6 stimulates lipolysis in porcine adipocytes. Endocrine (Epublication ahead of print version; doi: 10.1007/s12020-008- 9085-7).
137. van Hall G, Steenberg A, Sacchetti M et al. (2003) Interleukin- 6 stimulates lipolysis and fat oxidation in humans. J ClinEndocrinol Metab 88, 3005-3010.
138. Al-Khalili L, Bouzakri K, Glund S et al. (2006) Signaling specificity of interleukin-6 action on glucose and lipid metabolism in skeletal muscle. Mol Endocrinol 20, 3364-3375.
139. Carey AL, Steinberg GR, Macaulay SL et al. (2006) Interleukin- 6 increases insulin-stimulated glucose disposal in humans and glucose uptake and fatty acid oxidation in vitro via AMP-activated protein kinase. Diabetes 55, 2688-2697.
140. Kristiansen OP & Mandrup-Poulsen T (2005) Interleukin-6 and diabetes: the good, the bad, or the indifferent? Diabetes 54, Suppl. 2, S114-S124.
141. Carey AL, Petersen EW, Bruce CR et al. (2006) Discordant gene expression in skeletal muscle and adipose tissue of patients with type 2 diabetes: effect of interleukin-6 infusion. Diabetologia 49, 1000-1007.
142. Feingold KR, Doerrler W, Dinarello CA et al. (1992) Stimulation of lipolysis in cultured fat cells by tumor necrosis factor, interleukin-1, and the interferons is blocked by inhibition of prostaglandin synthesis. Endocrinology 130, 10-16.
143. Doerrler W, Feingold KR & Grunfeld C (1994) Cytokines induce catabolic effects in cultured adipocytes by multiple mechanisms. Cytokine 6, 478-484.
144. Delikat SE, Galvani DW & Zuzel M (1995) The metabolic effects of interleukin 1 beta on human bone marrow adipocytes. Cytokine 7, 338-343.
145. Lagathu C, Yvan-Charvet L, Bastard JP et al. (2006) Longterm treatment with interleukin-1beta induces insulin resistance in murine and human adipocytes. Diabetologia 49, 2162-2173.
146. Suganami T, Nishida J & Ogawa Y (2005) A paracrine loop between adipocytes and macrophages aggravates inflammatory changes: role of free fatty acids and tumor necrosis factor alpha. Arterioscler Thromb Vasc Biol 25, 2062-2068.
147. Suganami T, Tanimoto-Koyama K, Nishida J et al. (2007) Role of the Toll-like receptor 4/NF-kappaB pathway in saturated fatty acid-induced inflammatory changes in the interaction between adipocytes and macrophages. Arterioscler Thromb Vasc Biol 27, 84-91.
148. Lee JY, Sohn KH, Rhee SH et al. (2001) Saturated fatty acids, but not unsaturated fatty acids, induce the expression of cyclooxygenase-2 mediated through Toll-like receptor 4. J Biol Chem 276, 16683-16689.
149. Capel F, Klimcakova E, Viguerie N et al. (2009) Macrophages and adipocytes in human obesity: gene expression and insulin sensitivity during calorie restriction and weight stabilization. Diabetes (In the Press).